TSR-042 as Maintenance Therapy for Patients With High-risk Locally Advanced Cervical Cancer After Chemo-radiation

NCT03833479 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

134

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer
Advanced Cancer

Interventions

OTHER: No Further Treatment
DRUG: TSR-042

Sponsor

Grupo Español de Investigación en Cáncer de Ovario

Collaborators

[object Object]
[object Object]